Taylor Ben R 4
4 · RECURSION PHARMACEUTICALS, INC. · Filed Feb 5, 2025
Insider Transaction Report
Form 4
Taylor Ben R
Chief Financial Officer
Transactions
- Award
Class A Common Stock
2025-02-03+35,018→ 879,228 total - Award
Class A Common Stock
2025-02-03+13,922→ 893,150 total - Tax Payment
Class A Common Stock
2025-02-03$7.25/sh−6,544$47,444→ 886,606 total - Award
Stock Option (Right to Buy)
2025-02-03+70,037→ 70,037 totalExercise: $7.25Exp: 2035-02-03→ Class A Common Stock (70,037 underlying)
Holdings
- 289,837
Stock Option (Right to Buy)
Exercise: $0.04Exp: 2030-11-26→ Class A Common Stock (0 underlying) - 740,686
Stock Option (Right to Buy)
Exercise: $6.09Exp: 2034-12-18→ Class A Common Stock (0 underlying) - 92,748
Stock Option (Right to Buy)
Exercise: $0.06Exp: 2031-04-02→ Class A Common Stock (0 underlying) - 81,154
Stock Option (Right to Buy)
Exercise: $0.14Exp: 2031-07-01→ Class A Common Stock (0 underlying)
Footnotes (8)
- [F1]This RSU vests as to one one-sixteenth (1/16th) of the units subject the RSU on May 15, 2025 and every three months thereafter.
- [F2]This RSU vested immediately upon the grant date.
- [F3]Represents shares that have been withheld by the Issuer to satisfy its tax withholding and remittance obligations in connection with the net settlement of restricted stock units.
- [F4]The option vests as to one forty-eighth (1/48th) of the shares subject to the option on March 1, 2025, and one forty-eighth (1/48th) of the shares subject to the option will vest each month thereafter.
- [F5]Twenty-five percent of the shares subject to the award vest and become exercisable on November 17, 2021, and the remaining shares subject to the award vest and become exercisable in annual installments thereafter, subject to Mr. Taylor's continued service through each vesting date.
- [F6]Twenty-five percent of the shares subject to the award vest and become exercisable on April 3, 2022, and the remaining shares subject to the award vest and become exercisable in quarterly installments thereafter, subject to Mr. Taylor's continued service through each vesting date.
- [F7]Twenty-five percent of the shares subject to the award vest and become exercisable on July 1, 2022, and the remaining shares subject to the award vest and become exercisable in quarterly installments thereafter, subject to Mr. Taylor's continued service through each vesting date.
- [F8]1/48th of the shares subject to the award vests and become exercisable on January 2, 2025, and each month thereafter, subject to Mr. Taylor's continued service through each vesting date.